Archives
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
Polymyxin B (Sulfate): A Translational Powerhouse for Tac...
2025-10-03
Explore how Polymyxin B (sulfate) bridges potent antimicrobial action with immune modulation—unlocking new translational research avenues in infection models, dendritic cell biology, and immunometabolic regulation. This thought-leadership piece delivers mechanistic depth, strategic guidance, and a visionary outlook for researchers seeking to outpace the evolving threat of multidrug-resistant Gram-negative bacteria.
-
Polymyxin B Sulfate: Advanced Workflows for Gram-Negative...
2025-10-02
Polymyxin B (sulfate) is redefining laboratory approaches to multidrug-resistant Gram-negative bacterial infections with its dual antimicrobial and immunomodulatory actions. This guide delivers actionable protocols, troubleshooting insights, and explores cutting-edge applications from sepsis models to dendritic cell maturation assays, setting a new research standard.
-
Polymyxin B (Sulfate): From Bactericidal Agent to Transla...
2025-10-01
This thought-leadership article guides translational researchers through the evolving landscape of Polymyxin B (sulfate), a polypeptide antibiotic traditionally employed against multidrug-resistant Gram-negative bacteria. Integrating mechanistic insights—such as its cationic detergent action and immunomodulatory roles—alongside new evidence from immune balance and microbiota studies, the article provides strategic guidance for advanced infection models, immune assays, and translational workflows. It differentiates itself from standard product pages by contextualizing Polymyxin B in immunometabolic research and host-microbiome interplay, offering actionable perspectives for innovators in infectious disease research.
-
Polymyxin B Sulfate: Optimizing Research on Multidrug-Res...
2025-09-30
Polymyxin B (sulfate) is redefining infection research, offering robust activity against multidrug-resistant Gram-negative bacteria and unique immunomodulatory effects. This guide translates bench protocols into actionable workflows, highlights advanced use-cases, and empowers researchers with troubleshooting strategies to maximize experimental outcomes.
-
Polymyxin B (Sulfate): Next-Gen Immunomodulation in Infec...
2025-09-29
Explore the multifaceted roles of Polymyxin B sulfate as a polypeptide antibiotic for multidrug-resistant Gram-negative bacteria. This article uniquely examines its emerging applications in immune signaling, microbiota modulation, and translational research, revealing connections rarely addressed elsewhere.
-
Polymyxin B (Sulfate): A Systems Biology Perspective on I...
2025-09-28
Explore the multifaceted role of Polymyxin B sulfate as a polypeptide antibiotic for multidrug-resistant Gram-negative bacteria. This article uniquely examines its systems-level effects on immune signaling and microbiota, revealing new avenues for translational research in infection and immunity.
-
Polymyxin B Sulfate: Beyond Antibiotic—A Gateway to Immun...
2025-09-27
Discover how Polymyxin B sulfate, a potent polypeptide antibiotic for multidrug-resistant Gram-negative bacteria, is advancing immune modulation research and translational applications. This article uniquely explores mechanistic insights, in vivo immunological effects, and emerging roles in sepsis models.
-
CHIR 99021 Trihydrochloride: Precision GSK-3 Inhibition f...
2025-09-26
Explore how CHIR 99021 trihydrochloride, a potent GSK-3 inhibitor, enables unprecedented precision in balancing stem cell self-renewal and differentiation. This article uniquely examines its mechanistic impact on human organoid systems and advanced metabolic disease modeling.
-
Pseudo-UTP: Revolutionizing RNA Stability for mRNA Vaccin...
2025-09-25
Explore the science behind Pseudo-modified uridine triphosphate (Pseudo-UTP) for in vitro transcription, uncovering its unique mechanisms that enhance RNA stability and translation efficiency. This in-depth article provides advanced insights for mRNA vaccine development and gene therapy, setting it apart from standard overviews.
-
Cyclopamine in Translational Research: Precision Hedgehog...
2025-09-24
Explore how Cyclopamine, a Hedgehog signaling inhibitor, is driving next-generation cancer and developmental studies through advanced mechanistic insights and translational strategies. This article uniquely integrates recent comparative developmental findings and experimental design guidance for maximizing research impact.
-
Sulfo-NHS-SS-Biotin Kit: Advanced Tools for Cell Surface ...
2025-09-23
Explore the Sulfo-NHS-SS-Biotin Kit, a water-soluble amine-reactive biotinylation reagent, for precise and reversible cell surface protein labeling. This article delves into its unique utility in dissecting emerging cell surface glycoRNA-RBP domains and expands on applications beyond traditional protein and antibody biotinylation for purification.
-
Salvia the largest genus in the family Lamiaceae
2025-03-03

Salvia, the largest genus in the family Lamiaceae, comprises over 900 species that are distributed globally [14], [15], [16]. The genus Salvia has been assessed in many studies because it is a rich source of polyphenol compounds, of which more than 160 have been isolated from plants in the genus, so
-
It thus appeared reasonable that AR
2025-03-03

It thus appeared reasonable that AR needed to be inhibited and great experimental efforts began which are still on-going [6]. Indeed, hundreds of ARIs have been characterized but no significant drug development has followed. The case of Sorbinil, which did not pass clinical trials is emblematic [7]
-
The fact that Yoda can activate
2025-03-03

The fact that Yoda1 can activate Piezo1 in the absence of other cellular components other than a cell membrane [2], suggests that it may directly interact with and activate Piezo1. However, this does not preclude Yoda1 from interacting and activating non-Piezo channels, particularly in endothelial c
-
Tissue distribution showed that ctrp was abundantly expresse
2025-03-03

Tissue distribution showed that ctrp9 was abundantly expressed in the kidney of male and female tilapia. In mice, the Ctrp9 was identified in adipose tissue, and the expression levels were higher in females than that of males (Wong et al., 2009). Recent studies indicated that Ctrp9 was also expresse